Search
01/10/2025
European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase
Ostermann, M, Alshamsi, F, Raventos, AA, Cecconi, M, Ichai, C, Jones, C, Malbrain, MLNG, Monnet, X, Nalos, M, Peng, ZY, Pfortmueller, CA, Prowle, J, Ranzani, O, Shankar-Hari, M, Wong, A, Moller, MH, De Backer, D. European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase. INTENSIVE CARE MEDICINE. 2025; 51(10)DOI:10.1007/s00134-025-08058-x. PMID:40828463. IF:21.200(Q1/1D).
01/09/2025
Allostatic overload as the pathophysiological basis for integrating palliative care in the Intensive Care Unit
Forte, DN, Ramos, JGR, Ranzani, OT. Allostatic overload as the pathophysiological basis for integrating palliative care in the Intensive Care Unit. INTENSIVE CARE MEDICINE. 2025; 51(9)DOI:10.1007/s00134-025-08054-1. PMID:40736674. IF:21.200(Q1/1D).
01/08/2025
Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned
Rashan, A, Püttmann, DP, de Keizer, NF, Dongelmans, DA, Cornet, R, Ranzani, O, Waweru-Siika, W, Smith, M, Harris, S, Beane, A, Bakhshi-Raiez, F. Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned. Jamia Open. 2025; 8(4)DOI:10.1093/jamiaopen/ooaf052. PMID:40698026. IF:(Q/D).
01/06/2025
Telemedicine in critical care
Spies, CD, Ranzani, OT. Telemedicine in critical care. INTENSIVE CARE MEDICINE. 2025; 51(6)DOI:10.1007/s00134-025-07955-5. PMID:40471258. IF:21.200(Q1/1D).
25/11/2025
Difficulties on the access to innovative targeted therapies for lung cancer in Spain
Calvo V., Camps C., Carcereny E., Cobo M., Dómine M., García Campelo M.R., González Larriba J.L., Guirado M., Hernando-Trancho F., Massutí B., Nadal E., Rodríguez-Abreu D., Sánchez A., Sullivan I.G., Provencio M.. Difficulties on the access to innovative targeted therapies for lung cancer in Spain. Clinical & Translational Oncology. ; DOI:10.1007/s12094-023-03303-5. PMID:37651020. IF:(Q/D).
01/09/2025
Flaws and weaknesses in estimating the budget impact of lung cancer screening in Spain
Rosell, A, Estrada, O, López-Seguí, F, Vicente-Gómez, JA, Robledinos-Antón, N, Seijo, LM, Trujillog, JC. Flaws and weaknesses in estimating the budget impact of lung cancer screening in Spain. Gaceta Sanitaria. 2025; 39DOI:10.1016/j.gaceta.2025.102528. PMID:41016098. IF:1.500(Q3/7D).
17/11/2025
Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial
Lozano-Borbalas, A, Jordi-Ollero, O, Marruecos, J, Farre, N, Planas, I, Toledo, MD, Mesia, R, Navarro-Martin, A. Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1679589. PMID:41333216. IF:3.300(Q2/4D).
01/01/2023
Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.
Czerwinska-Jelonkiewicz K, Wood A, Bohm A, Kwasiborski P, Oleksiak A, Ryczek R, Grand J, Tavazzi G, Sionis A, Stepinska J. Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.. Cardiology Journal. 2023; 30(6)DOI:10.5603/CJ.a2021.0173. PMID:34967939. IF:2.500(Q2/5D).